Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New hope for hepatitis b patients who relapse after stopping treatment

NCT ID NCT04496882

First seen Feb 25, 2026 · Last updated May 22, 2026 · Updated 9 times

Summary

This study looks at whether switching to a newer antiviral drug (tenofovir alafenamide) can help people with chronic hepatitis B who experience a flare-up after stopping their previous medication. About 260 adults in Taiwan who had been on standard antivirals for at least a year and then stopped will be enrolled. The goal is to see if the new drug can control the virus and normalize liver enzyme levels.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Buddhist Tzu Chi General Hospital, Da-Lin Branch

    Chiayi City, Taiwan

  • Buddhist Tzu-Chi General Hospital Taipei Branch

    Taipei, Taiwan

  • Chia-Yi Christian Hospital

    Chiayi City, Taiwan

  • E-da hospital

    Kaohsiung City, Taiwan

  • National Taiwan University Hospital

    Taipei, 100, Taiwan

  • National Taiwan University Hospital ,Hsin-Chu Branch

    Hsinchu, Taiwan

  • National Taiwan University Hospital, Yun-Lin branch

    Douliu, Taiwan

  • Taipei City Hospital, Renai Branch

    Taipei, Taiwan

Conditions

Explore the condition pages connected to this study.